Oramed Pharmaceuticals inc
Oramed Pharmaceuticals has developed a technology to transform injectable treatments into oral therapies. The company's flagship product, an oral insulin capsule would allow type 2 diabetes patients to begin insulin therapy earlier without injections. Oramed's oral insulin is currently in advanced clinical trials under the US FDA for both type 1 and type 2 diabetes.
756thin Middle East